{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:34:59Z","timestamp":1793730899152,"version":"4.6.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12883-016-0578-3","type":"journal-article","created":{"date-parts":[[2016,4,26]],"date-time":"2016-04-26T01:26:39Z","timestamp":1461633999000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["CNS vasculitis and stroke as a complication of DOCK8 deficiency: a case report"],"prefix":"10.1186","volume":"16","author":[{"given":"Suzan A.","family":"AlKhater","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,4,26]]},"reference":[{"key":"578_CR1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4103\/2230-8229.96520","volume":"16","author":"SA AlKhater","year":"2009","unstructured":"AlKhater SA. Approach to the child with recurrent infections. J Family Community Med. 2009;16:77\u201382.","journal-title":"J Family Community Med"},{"key":"578_CR2","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s12016-012-8345-8","volume":"45","author":"S Gupta","year":"2013","unstructured":"Gupta S, Louis AG. Tolerance and autoimmunity in primary immunodeficiency disease: a comprehensive review. Clin Rev Allergy Immunol. 2013;45:162\u20139.","journal-title":"Clin Rev Allergy Immunol"},{"key":"578_CR3","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s11882-013-0350-3","volume":"13","author":"K Todoric","year":"2013","unstructured":"Todoric K, Koontz JB, Mattox D, Tarrant TK. Autoimmunity in immunodeficiency. Curr Allergy Asthma Rep. 2013;13:361\u201370.","journal-title":"Curr Allergy Asthma Rep"},{"key":"578_CR4","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0065-2776(05)89008-X","volume":"89","author":"LD Notarangelo","year":"2006","unstructured":"Notarangelo LD, Gambineri E, Badolato R. Immunodeficiencies with autoimmune consequences. Adv Immunol. 2006;89:321\u201370.","journal-title":"Adv Immunol"},{"key":"578_CR5","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1542\/peds.49.1.59","volume":"49","author":"RH Buckley","year":"1972","unstructured":"Buckley RH, Wray BB, Belmaker EZ. Extreme hyperimmunoglobulin E and undue susceptibility to infections. Pediatrics. 1972;49:59\u201370.","journal-title":"Pediatrics"},{"key":"578_CR6","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1056\/NEJM199903043400904","volume":"340","author":"B Grimbacher","year":"1999","unstructured":"Grimbacher B, Holland SM, Gallin JI, Greenberg F, Hill SC, Malech HL, et al. Hyper-IgE syndrome with recurrent infections \u2013 an autosomal dominant multisystem disorder. N Engl J Med. 1999;340:692\u2013702.","journal-title":"N Engl J Med"},{"key":"578_CR7","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1056\/NEJMoa073687","volume":"357","author":"SM Holland","year":"2007","unstructured":"Holland SM, DeLeo FR, Ellourni HZ. STAT3 mutations in the hyper-IgE syndrome. N Engl J Med. 2007;357:1608\u201319.","journal-title":"N Engl J Med"},{"key":"578_CR8","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.jaci.2009.10.038","volume":"124","author":"KR Engelhardt","year":"2009","unstructured":"Engelhardt KR, McGhee S, Winkler S, Sassi A, Woellner C, Lopez-Herrera G, et al. Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome. J Allergy Clin Immunol. 2009;124:1289\u2013302.","journal-title":"J Allergy Clin Immunol"},{"key":"578_CR9","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1056\/NEJMoa0905506","volume":"361","author":"Q Zhang","year":"2009","unstructured":"Zhang Q, Davis JC, Lamborn IT, Freeman AF, Jing H, Favreau AJ, et al. Combined immunodeficiency associated with DOCK8 mutations. N Engl J Med. 2009;361:2046\u201355.","journal-title":"N Engl J Med"},{"key":"578_CR10","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0022-3476(03)00449-9","volume":"144","author":"ED Renner","year":"2004","unstructured":"Renner ED, Puck JM, Holland SM, Schmitt M, Frosch M, Bergmann M, et al. Autosomal recessive hyperimmunoglobulin E syndrome: a distinct disease entity. J Pediatr. 2004;144:93\u20139.","journal-title":"J Pediatr"},{"key":"578_CR11","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.immuni.2006.09.009","volume":"25","author":"Y Minegishi","year":"2006","unstructured":"Minegishi Y, Saito M, Morio T, Watanabe K, Agematsu K, Tsuchiya S, et al. Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity. Immunity. 2006;25:745\u201355.","journal-title":"Immunity"},{"key":"578_CR12","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1365-2249.2009.04044.x","volume":"159","author":"H Yavuz","year":"2010","unstructured":"Yavuz H, Chee R. A review on the vascular features of the hyperimmunoglobulin E syndrome. Clin Exp Immunol. 2010;159:238\u201344.","journal-title":"Clin Exp Immunol"},{"key":"578_CR13","doi-asserted-by":"crossref","first-page":"e1121","DOI":"10.1542\/peds.2006-2649","volume":"119","author":"AF Freeman","year":"2007","unstructured":"Freeman AF, Collura-Burke CJ, Patronas NJ, IIcus LS, Darnell D, Davis J, et al. Brain abnormalities in patients with hyperimmunoglobulin E syndrome. Pediatrics. 2007;119:e1121\u20135.","journal-title":"Pediatrics"},{"key":"578_CR14","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/ACI.0b013e32833fd718","volume":"10","author":"HC Su","year":"2010","unstructured":"Su HC. Dedicator of cytokinesis 8 (DOCK8) deficiency. Curr Opin Allergy Clin Immunol. 2010;10:515\u201320.","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"578_CR15","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1749-6632.2011.06295.x","volume":"1246","author":"HC Su","year":"2011","unstructured":"Su HC, Jing H, Zhang Q. DOCK8 deficiency. Ann NY Acad Sci. 2011;1246:26\u201333.","journal-title":"Ann NY Acad Sci"},{"key":"578_CR16","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s10875-012-9769-x","volume":"33","author":"Z Alsum","year":"2013","unstructured":"Alsum Z, Hawwari A, Alsmadi O, Al-Hissi S, Borrero E, Abu-staiteh S, et al. Clinical, immunological and molecular characterization of DOCK8 and DOCK8-like deficient patients: single center experience of twenty-five patients. J Clin Immunol. 2013;33:55\u201367.","journal-title":"J Clin Immunol"},{"key":"578_CR17","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/S1474-4422(10)70243-X","volume":"9","author":"C Hutchinson","year":"2010","unstructured":"Hutchinson C, Elbers J, Halliday W, Branson H, Laughlin S, Armstrong D, et al. Treatment of small vessel primary CNS vasculitis in children: an open-label cohort study. Lancet Neurol. 2010;9:1078\u201384.","journal-title":"Lancet Neurol"},{"key":"578_CR18","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0162-3109(00)00188-0","volume":"47","author":"AC Allison","year":"2000","unstructured":"Allison AC, Eugui EM. Mycophenolate mofetil and its mechanisms of action. Immunopharmacology. 2000;47:85\u2013118.","journal-title":"Immunopharmacology"},{"key":"578_CR19","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejphar.2012.03.037","volume":"684","author":"A Chauhan","year":"2012","unstructured":"Chauhan A, Sharma U, Reeta KH, Jagannathan NR, Mehra RD, Gupta YK. Neuroimaging, biochemical and cellular evidence of protection by mycophenolate mofetil on middle cerebral artery occlusion induced injury in rats. Eur J Pharmacol. 2012;684:71\u20138.","journal-title":"Eur J Pharmacol"},{"key":"578_CR20","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1046\/j.1460-9568.2003.02821.x","volume":"18","author":"F Dehghani","year":"2003","unstructured":"Dehghani F, Hischebeth GT, Wirjatijasa F, Kohl A, Korf HW, Hailer NP. The immunosuppressant mycophenolate mofetil attenuates neuronal damage after excitotoxic injury in hippocampal slice cultures. Eur J Neurosci. 2003;18:1061\u201372.","journal-title":"Eur J Neurosci"},{"key":"578_CR21","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1093\/rheumatology\/kep120","volume":"48","author":"A Mak","year":"2009","unstructured":"Mak A, Cheak AAC, Tan JYS, Su HC, Ho RCM, Lau CS. Mycophenolate mofetil is as efficacious as, but safer than, cyclophosphamide in the treatment of proliferative lupus nephritis: a meta-analysis and meta-regression. Rheumatology. 2009;48:944\u201352.","journal-title":"Rheumatology"},{"key":"578_CR22","first-page":"1228","volume":"35","author":"J Brunner","year":"2008","unstructured":"Brunner J, Armstrong D, Feldman BM, Schneider R, Benseler S. Childhood strokes as the presentation of Takayasu's arteritis: diagnostic delay can cause catastrophic complications. J Rheumatol. 2008;35:1228\u201330.","journal-title":"J Rheumatol"},{"key":"578_CR23","first-page":"311","volume":"8","author":"S Taraman","year":"2010","unstructured":"Taraman S, Jani-Acsadi A, Tselis A. Central nervous system vasculitis and pediatric stroke. J Pediatr Neurol. 2010;8:311\u20139.","journal-title":"J Pediatr Neurol"},{"key":"578_CR24","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1084\/jem.20040566","volume":"200","author":"M Paul-Clark","year":"2004","unstructured":"Paul-Clark M, van Cao T, Moradi-Bidhendi N, Cooper D, Gilroy D. 15-epi-lipoxin a sub(4)-mediated induction of nitric oxide explains How aspirin inhibits acute inflammation. J Exp Med. 2004;200:69\u201378.","journal-title":"J Exp Med"},{"key":"578_CR25","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1160\/TH15-03-0191","volume":"114","author":"T Hohlfeld","year":"2015","unstructured":"Hohlfeld T, Schror K. Antiinflammatory effects of aspirin in ACS: relevant to its cardiocoronary actions? Thromb Haemostasis. 2015;114:469\u201377.","journal-title":"Thromb Haemostasis"},{"key":"578_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11940-015-0349-2","volume":"17","author":"M Steinlin","year":"2015","unstructured":"Steinlin M, Mackay MT. Emergency management of ischemic stroke in children. Curr Treat Option Neurol. 2015;17:1\u201314.","journal-title":"Curr Treat Option Neurol"},{"key":"578_CR27","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2147\/TACG.S42772","volume":"2015","author":"M Kossorotoff","year":"2015","unstructured":"Kossorotoff M, Tournier-Lasserve E, Herve D, Guey S. Moyamoya disease and syndromes: from genetics to clinical management. Appl Clin Genet. 2015;2015:49\u201368.","journal-title":"Appl Clin Genet"},{"key":"578_CR28","unstructured":"Chen JB, Liu Y, Zhou LX, Sun H, He M, You C. Increased prevalence of autoimmune disease in patients with unilateral compared with bilateral moyamoya disease. J Neurosurg. 2015;123:1\u20136. Published online September 25, 2015; doi: 10.3171\/2015.4 . JNS142936."},{"key":"578_CR29","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.pediatrneurol.2005.10.003","volume":"34","author":"MF Rafay","year":"2006","unstructured":"Rafay MF, Smith SE, Dirks P, Armstrong D, DeVeber GA. Hemorrhage predisposing to cerebral infarction in children with Moyamoya disease. Pediatr Neurol. 2006;34:400\u20134.","journal-title":"Pediatr Neurol"},{"key":"578_CR30","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/bmt.2010.169","volume":"46","author":"SA Gatz","year":"2011","unstructured":"Gatz SA, Benninghoff U, Sch\u00fctz C, Schulz A, H\u00f6nig M, Pannicke U, et al. Curative treatment of autosomal-recessive hyper-IgE syndrome by hematopoietic cell transplantation. Bone Marrow Transplant. 2011;46:552\u20136.","journal-title":"Bone Marrow Transplant"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-016-0578-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T19:36:16Z","timestamp":1692300976000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-016-0578-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,26]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["578"],"URL":"https:\/\/doi.org\/10.1186\/s12883-016-0578-3","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,26]]},"article-number":"54"}}